In-Source Photoderivatization-Enhanced Neurometabolic Profiling Deciphers Vascular Cognitive Impairment

This is the authors' abstract. We don't add key points for this paper.

Neurometabolic profiling in population samples across different stages of vascular cognitive impairment (VCI) holds great promise for elucidating the disease’s pathogenesis. However, high-throughput neurometabolic profiling remains challenging due to the limited detection of low-abundance metabolites with poor ionization efficiency. Here, we present a novel photoreactive probe, 5-methoxy-2-nitrobenzaldehyde, combined with TiO 2 P25, to create a mass spectrometry in-source photoderivatization (MSIPD) platform for neurometabolic profiling, with a focus on enhancing the detection of neurotransmitters (NTs). This platform allows for covalent and nanosecond laser-triggered derivatization of monoamine NTs and a 2-fold increase in metabolite coverage compared to underivatized samples, using laser desorption/ionization mass spectrometry (LDI-MS). Our approach demonstrates high derivatization efficiency (over 93%), high reproducibility (≤8.2%), minimal sample consumption (∼1 μL), and rapid analysis speed (∼5 s per sample), without complex sample pretreatment. Application to CSF from 103 VCI patients and 100 controls revealed 12 significantly altered neuro-metabolites. An additional cohort of 131 VCI patients stratified by cognitive status showed stage-dependent alterations, including decreased histamine, histidine, phenylalanine, and homovanillic acid in severe cases, corroborated in a mouse model of cerebral ischemia. These findings underscore NT metabolic dysregulation in VCI pathogenesis and establish MSIPD as a powerful tool for translational neurometabolic profiling.